4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000950170-25-088604
10% owner sold 334,801 shares at an average $30.19 ($10,107,818)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. 10% owner | 2025-06-18 | Sale | −100,000 | $29.95 | $2,995,000 | 1,148,789 | I |
| Versant Venture Capital VI, L.P. 10% owner | 2025-06-20 | Sale | −100,877 | $30.35 | $3,061,617 | 1,047,912 | I |
| Versant Venture Capital VI, L.P. 10% owner | 2025-06-20 | Sale | −133,924 | $30.25 | $4,051,201 | 1,967,275 | D |
| Open-market sales · 334,801 sh · avg $30.19 · $10,107,818 | |||||||
Loading xslF345X05/ownership.xml…